A. Mandi, G. Galgoczy, E. Galambos and R. Aurich,Histamine protection and bronchodilation with azelatine, a new antiallergic compound. Bull. Eur. Physiopathologic Respiratoire17 (1), 5P (1981).
P. Atkins, H. Merton, P. Karpink, I. Weliky and B. Zweiman,Azelastine inhibition of skin test reactivity in humans. J. Allergy Clin. Immunol.75 (1), 167 (1985)
S. Motojima, Y. Ohashi, T. Otsuk, T. Fukuda and S. Makino,Effects of azelastine on allergen- and exercise-induced asthma. Asian Pacific J. Allergy Immun.3, 174–178 (1985).
S. L. Spector, J. L. Perhach, A. S. Rohr, G. S. Rachelefsky, R. M. Katz and S. C. Siegel,Pharmacodynamic evaluation of azelastine in subjects with asthma
. J. Allergy Clin. Immunol.80
, 75–80 (1987).PubMed
S. Ollier, C. A. L. Gould and R. J. Davies,The effect of single and multiple dose therapy with azelastine on the immediate asthmatic response to allergen provocation testing
. J. Allergy Clin. Immunol.78
, 358–364 (1986).PubMed
N. Chand, J. Pillar, W. Diamantis, J. L. Perhach Jr. and R. D. Sofia,Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: implications for its mode of action. Europ. J. Pharmacol.96, 227–233 (1983).
N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of IgE-mediated allergic histamine release from rat peritoneal mast cells by azelastine and selected antiallergic drugs
. Agents and Actions16
(5), 318–322 (1985).PubMed
D. A. S. Fields, J. Pillar, W. Diamantis, J. L. Perhach Jr., R. D. Sofia and N. Chand,Inhibition by azelastine of nonallergic histamine release from rat peritoneal mast cells
. J. Allergy Clin. Immunol.73
(3), 400–403 (1984).PubMed
N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabgit leukocytes. Int. Arch. Allergy Apply. Immunol.77, 451–455 (1985).
M. M. Little and T. B. Casale,Azelastine inhibits both human lung and basophil degranulation. J. Allergy Clin. Immunol.79 (1), 204 (1987).
N. Chand, J. Pillar, K. Nolan, W. Diamantis and R. D. Sofia,Inhibition of 5-HETE, LTB
synthesis by azelastine and its d- and l-isomers in rat mixed peritoneal cells. Amer. Rev. Resp. Dis.135, A318 (1987).
N. Chand, W. Diamantis, K. Nolan, J. Pillar and R. D. Sofia,Inhibition of allergic leukotriene C
4)formation by azelastine in actively sensitized chopped guinea pig lung. Pharmacologist29, 173 (1987).
K. Taniguchi, and K. Takanaka,Inhibitory effects of various drugs on phorbol myristate acetate and n-formyl-methionyl-leucyl-phenulalanine induced O
production in polymorphonuclear leukocytes
. Biochem. Pharmacol.33
(20), 3165–3169 (1984).PubMed
N. Chand, W. Diamantis and R. D. Sofia, Antagonism of leukotrienses, calcium and histamine by azelastine. Pharmacologist26, 152 (1984).
N. Chand, W. Diamantis and R. D. Sofia, Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents and Actions19
(3–4), 164–168 (1986).PubMed
N. Chand, K. Nolan, W. Diamantis, J. L. Perhach and R. D. Sofia,Inhibition of leukotriene (SRS-A)-mediated acute lung anaphylaxis by azelastine in guinea pigs
, 473–478 (1986).PubMed
N. Chand, K. Nolan, W. Diamantis and R. D. Sofia,Inhibition of acute lung anaphylaxis by aerosolized azelastine in guinea pigs sensitized by three different procedures
. Annals of Allergy58
(5), 344–349 (1987).PubMed
N. Chand, J. E. Harrison, S. M. Rooney, R. D. Sofia and W. Diamantis,Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties
. Int. J. Immunopharmacol.7
(6), 833–838 (1985).PubMed
A. R. Means, J. S. Task and J. G. Chafouleas,Physiological implications of the presence, distribution, and regulation of calmodulin ineukaryotic cells. Physiol. Res.62, 1–39 (1982).
G. Marone, M. Columbo, S. Poto, R. Giugliano and M. Condorelli,Possible role of calmodulin in the control of histamine release from human basophil leukocytes
. Life Sci.39
, 911–922 (1986).PubMed
H. Hidaka, M. Asano, S. Iwadare, I. Matsumoto, T. Totsuka and N. Aoki,A novel vascular relaxing agent, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide which affects vascular smooth muscle actomyosin
. J. Pharmacol. Exp. Ther.207
, 8–15 (1978).PubMed
Y. Nishizuka,Studies and perspectives of protein kinase C
, 305–312 (1986).PubMed
H. Nishino, A. Naito Iwashima, K. Tanaka, T. Matsuura, H. Fujiki and T. Sugimura,Interaction between quercetin and Ca
2+-calmodulin complex: Possible mechanism for antitumor-promoting action of the flavonoid. Gann74, 311–316 (1984).
H. Hidaka and T. Tanaka,Naphthalenesulfonamides as calmodulin antagonists. Methods Enzymol.102, 185–194.
R. W. Butcher and E. W. Sutherland,Adenosine 3′, 5′-phosphate in biological materials. I. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine
. J. Biol. Chem.237
, 1244–1250 (1962).PubMed
C. H. Fiske and Y. SubbaRow,Colorimetric determination of phosphorous. J. Biol. Chem.66, 375–400 (1925).
U. Kikkawa, Y. Takai, R. Minakuchi, S. Inohara and Y. Nishizuka,Calcium-activated, phospholipid-dependent protein kinase from rat brain
. Subcellular distribution, purification and properties. J. Biol. Chem.257
, 13341–13348 (1982).PubMed
I. H. Segel, In:Enzyme Kinetics: Behavior and Analysis of Rapid Equilbrium and Steady-State Enzyme Systems, pp. 71 and 217, John Wiley & Sons, New York.
M. M. Bradford,A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dyne binding
. Anal. Biochem.72
, 248–254 (1976).PubMed
M. Gschwendt, F. Horn, W. Kittstein and F. Marrks,Inhibition of the calcium- and phospholipid-dependent protein kinase activity from mouse brain cytosol by quercetin. Biochem. Biophys. Res. Comm.177, 444–447 (1983).
P. M. Epstein, K. Fiss, R. Hachisu and D. M. Andrenyak,Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin
. Biochem. Biophys. Res. Commun.105
, 1142–1149 (1982).PubMed